The Gram-negative bacterium Burkholderia pseudomallei is the causative agent of melioidosis. d-glycero--d-manno-Heptose-1-phosphate adenylyltransferase (HldC) is the fourth enzyme of the ADP-l-glycero--d-manno-heptose biosynthesis pathway, which produces an essential carbohydrate comprising the inner core of lipopolysaccharide. Therefore, HldC is a potential target of antibiotics against melioidosis. In this study, HldC from B. pseudomallei has been cloned, expressed, purified and crystallized. Synchrotron X-ray data from a selenomethionine-substituted HldC crystal were also collected to 2.8 Å resolution. The crystal belonged to the primitive triclinic space group P1, with unit-cell parameters a = 74.0, b = 74.0, c = 74.9 Å , = 108.4, = 108.4, = 108.0 . Eight protomers are present in the unit cell and three out of five selenomethionines were found in each protomer using the PHENIX software suite. A full structural determination is in progress to elucidate the structurefunction relationship of the protein.
Introduction
Melioidosis is an infectious disease that is commonly found in Northern Australia and Southeast Asia (Currie et al., 2008) . It is the third highest cause of death from infectious diseases in northeast Thailand (Limmathurotsakul et al., 2010) and the fifth in Singapore (Liu et al., 2015) . The Gram-negative bacterium Burkholderia pseudomallei, the causative agent of melioidosis, has been classified as a potential bioterrorism agent owing to its high accessibility, environmental persistence, high mortality and the lack of an available vaccine (Gilad et al., 2007) . It also exhibits resistance to various groups of antibiotics, including penicillins, cephalosporins, rifamycins and aminoglycosides (Cheng & Currie, 2005) . Therefore, intensive research to understand the biology of B. pseudomallei and to develop antibiotics against melioidosis is required.
In most Gram-negative bacteria, lipopolysaccharide (LPS) is a principal component of the outer membrane. LPS is responsible for the structural integrity and strength of the bacterial outer membrane and its impermeability to toxic hydrophobic compounds (Nikaido & Vaara, 1985) . LPS consists of three covalently linked structures known as lipid A, a central core oligosaccharide and an O-specific polysaccharide side chain (Wiese et al., 1999) . The core oligosaccharide can be subdivided into two regions: an outer core and an inner core. The inner core contains two or three l-glycero-d-manno-heptoses and one to three 3-deoxy-dmanno-oct-2-ulosonic acids (Heinrichs et al., 1999) . Mutation of the genes related to the heptose biosynthesis pathway leads # 2017 International Union of Crystallography to loss of virulence and increased sensitivity to antibiotics in some organisms (Harper et al., 2004; Hiratsuka et al., 2005; Kim, 2003) and death in Pseudomonas aeruginosa (Walsh et al., 2000) . Therefore, the heptose biosynthesis pathway is considered to be an attractive target for new antibiotics.
d-glycero--d-manno-Heptose-1-phosphate adenylyltransferase (HldC, formerly RfaE or HldE2) is the fourth enzyme of the biosynthetic pathway for ADP-l-glycero--d-mannoheptose (Fig. 1) . In many species, the bifunctional enzyme HldE catalyzes the second and fourth steps of the pathway. HldE is composed of an N-terminal kinase domain and a C-terminal adenylyltransferase domain (Kneidinger et al., 2002) , which are homologous to d-glycero-d-manno-heptose-7-phosphate kinase (HldA) and HldC, respectively. HldC transfers the AMP moiety from ATP to d-glycero--dmanno-heptose-1-phosphate and releases ADP-d-glycero--d-manno-heptose and pyrophosphate. The crystal structure of HldA from B. cenocepacia has been determined (Lee et al., 2013) , but that of HldC has not yet been reported. To elucidate the structure-function relationship of HldC from B. pseudomallei (BpHldC), its crystallographic study has been carried out. Here, we report the cloning, overexpression, purification, crystallization and preliminary X-ray study of BpHldC.
Materials and methods
2.1. Macromolecule production 2.1.1. Cloning of rfaE from B. pseudomallei. The rfaE gene coding for the HldC protein (NCBI Reference Sequence YP_107021.1) was amplifled by PCR using 200 ng B. pseudomallei genomic DNA template and 50 mM of primers. The primer sequences used for ligation-independent cloning (LIC) are shown in Table 1 . PrimeSTAR HS DNA polymerase with GC buffer (Takara Bio Inc., Shiga, Japan) designed for high-GC-content genomic DNA was used. The LIC expression vector pB2 (Kim et al., 2005) , which expresses the cloned gene fused to a noncleavable N-terminal His 6 tag, was digested with SmaI. The PCR product treated with T4 DNA polymerase (New England Biolabs, Beverley, Massachusetts, USA) in the presence of dTTP was ligated with the digested vector incubated with T4 DNA polymerase in the presence of dATP. The ligation product was transformed into DH5 competent cells. Clones were screened by plasmid DNA analysis and transformed into Escherichia coli BL21 (DE3) cells for the expression of native BpHldC and E. coli B834 (DE3) cells for the expression of selenomethionine-substituted BpHldC (SeMet-BpHldC). BpHldC. E. coli BL21 (DE3) cells transformed with the cloned vector harbouring the rfaE gene were grown on LuriaBertani (LB) agar plates containing 150 mg ml À1 ampicillin. Several colonies were picked and grown in capped test tubes with 10 ml LB broth containing 150 mg ml À1 ampicillin. A cell stock of 0.85 ml culture and 0.15 ml glycerol was prepared and frozen at 193 K for use in a larger culture. The frozen cell stock was grown in 5 ml LB medium and diluted into 1000 ml fresh LB medium. The culture was incubated at 310 K with shaking until an OD 600 of 0.6-0.8 was reached. At this point, expression of BpHldC was induced using isopropyl -d-1-thiogalactopyranoside (IPTG) at a final concentration of 1 mM. The culture was further grown at 298 K for 16 h in a shaking incubator. Cells were harvested by centrifugation at 7650g (6500 rev min À1 ) for 10 min in a high-speed refrigerated centrifuge at 277 K. The cultured cell paste was resuspended in 25 ml of a buffer consisting of 50 mM Tris-HCl pH 8.0, 100 mM NaCl, 10 mM imidazole, 1 mM phenylmethylsulfonyl fluoride (PMSF), 10 mg ml À1 DNase I. The cell suspension was disrupted using a high-pressure homogenizer (Emulsiflex-B15, Avestin, Canada). Cell debris was pelleted by centrifugation at 24 900g (15 000 rev min À1 ) for 30 min in a high-speed refrigerated ultracentrifuge at 277 K.
The supernatant was affinity-purified using a HisTrap column on an Ä KTAexplorer system (GE Healthcare, Piscataway, New Jersey, USA). The column was equilibrated with a buffer consisting of 50 mM Tris-HCl pH 8.0, 300 mM NaCl, 10 mM imidazole. The target protein was eluted with a buffer consisting of 50 mM Tris-HCl pH 8.0, 100 mM NaCl with a gradient from 10 to 500 mM imidazole. The protein was further purified by ion-exchange chromatography using a 5 ml HiTrap Q column (GE Healthcare). The column was equilibrated with a buffer consisting of 20 mM Tris-HCl pH 8.5. The protein was eluted at 0.16 M NaCl using a linear NaCl gradient. The purified native HldC protein containing a noncleavable N-terminal His 6 tag was concentrated to 10 mg ml À1 for crystallization.
Protein expression and purification of SeMet-
BpHldC. To obtain SeMet-BpHldC, a frozen cell stock of E. coli B834 (DE3) cells was prepared using the same method as for E. coli BL21 (DE3) cells. The frozen cell stock was grown in 5 ml LB medium and diluted into 1000 ml medium containing M9 salts supplemented with 20%(w/v) glucose, 1 M MgSO 4 , 1 M CaCl 2 , 0.5%(w/v) thiamine, 100 mg ml À1 of each of arginine, histidine, isoleucine, leucine, glutamate, lysine, phenylalanine, cysteine and aspartate, 150 mg ml À1 valine, 400 mg ml À1 serine, 400 mg ml À1 threonine, 30 mg ml À1 tyrosine, 40 mg ml À1 tryptophan, 50 mg ml À1 l-selenomethionine and 150 mg ml À1 ampicillin. Protein expression and purification of SeMet-BpHldC was performed using the same protocol as for the native protein. The anion-exchange column was equilibrated with a buffer consisting of 20 mM Tris-HCl pH 8.0. The protein was eluted at 0.35 M NaCl using a linear NaCl gradient. The purified SeMet-BpHldC protein containing a noncleavable N-terminal His 6 tag was concentrated to 10 mg ml À1 for crystallization. The purity of native BpHldC and SeMet-BpHldC was checked on SDS-PAGE. They were also pretreated with 1 mM dithiothreitol (DTT) to run SDS-PAGE gels under reducing conditions.
Crystallization
Screening for initial crystallization conditions was performed with native BpHldC. Screening was carried out at room temperature using the sparse-matrix method (Jancarik & Kim, 1991) with several screens from Hampton Research (Laguna Niguel, California, USA). A Hydra-Plus-One crystallization robot (Matrix Technologies, Hudson, New Hampshire, USA) was used to set up the screens using the sitting-drop vapour-diffusion method in a 96-well Intelli-Plate (Art Robbins Instrument, Salt Lake City, Utah, USA). Sitting drops were made by mixing 0.2 ml protein solution with 0.2 ml reservoir solution and were equilibrated over 50 ml reservoir solution. Crystals of native BpHldC was obtained in the condition 0.1 M MES pH 6.5, 15%(w/v) polyethylene glycol 3350. A crystal of SeMet-BpHldC also appeared in the same condition. Optimization was performed using the hangingdrop vapour-diffusion method in a VDX48 plate (Hampton Research) by mixing 0.8 ml protein solution and 0.8 ml reservoir solution. To obtain high-quality crystals of SeMetBpHldC, detergent screening was carried out using Detergent Screen HT from Hampton Research. Finally, diffractionquality crystals of SeMet-BpHldC were obtained in 0.1 M HEPES pH 7.0, 20%(w/v) polyethylene glycol 3350, 8.5 mM n-octyl--d-thiomaltoside. A summary of the crystallization information is given in Table 2 .
Data collection and processing
Before being flash-cooled in liquid nitrogen, crystals were soaked in LV CryoOil (MiTeGen, Ithaca, New York, USA) as a cryoprotectant. X-ray diffraction data were collected at a single wavelength on beamline 7A at Pohang Light Source using an ADSC Quantum Q270r detector placed 300 mm from the sample. The data were collected at the peak absorption wavelength (f 00 ) for the selenomethionine-labelled protein ( = 0.97927 Å ) with inverse-beam geometry owing to rapid crystal decay. The oscillation range per image was 1 , with 1 s exposure. X-ray diffraction data were processed and scaled using iMosflm (Battye et al., 2011) and AIMLESS in the CCP4 suite (Winn et al., 2011) . 
Results and discussion
The yields of purified native BpHldC and SeMet-BpHldC were 100 and 22.6 mg per litre of E. coli culture, respectively. After anion-exchange chromatography, native BpHldC and SeMet-BpHldC appeared to be approximately 99% pure, with a prominent protein band at around 19 kDa on SDS-PAGE (Fig. 2) . Information on macromolecule production is summarized in Table 1 . At first, screening experiments for initial crystallization conditions were carried out using the native protein. Crystals of the native protein appeared with dimensions of 0.2 Â 0.1 Â 0.01 mm in 0.1 M MES pH 6.5, 15%(w/v) polyethylene glycol 3350. Crystals of the selenomethionine-labelled protein also appeared in the same condition as the native protein, but their size was relatively small. To produce larger crystals suitable for X-ray diffraction, the initial crystallization condition was optimized by varying the concentration of the precipitant and the pH of the buffer. Rod-shaped crystals of SeMet-BpHldC were obtained using 0.1 M HEPES pH 7.0, 20%(w/v) polyethylene glycol 3350, but the X-ray diffraction data from these crystals was not good enough for crystal phasing. Therefore, detergent screening was used to attempt to produce better diffraction-quality crystals. 
Figure 4
Diffraction pattern of a SeMet-BpHldC crystal. SeMet-BpHldC appeared in the presence of 8.5 mM n-octyl--d-thiomaltoside and grew to dimensions of 0.25 Â 0.15 Â 0.02 mm within a day at 296 K ( Fig. 3) . Single-wavelength anomalous dispersion (SAD) data were collected at 0.97927 Å from a SeMet-BpHldC crystal to 2.8 Å resolution (Fig. 4) . The crystal belonged to the primitive triclinic space group P1, with unit-cell parameters a = 74.0, b = 74.0, c = 74.9 Å , = 108.4, = 108.4, = 108.0
. Based on the Matthews coefficient (Matthews, 1968) , the asymmetric unit could contain eight protomers with 45.8% solvent content (V M = 3.67 Å 3 Da
À1
). Details of the data-collection statistics are presented in Table 3 . Crystallographic phases for the 2.8 Å resolution selenomethionine data set were obtained by SAD phasing. The substructure location and automatic model building were carried out using AutoSol and AutoBuild in the PHENIX software suite (Adams et al., 2010) . A relatively good electron-density map was calculated and an initial model containing eight protomers in the unit cell was obtained after automated model building. In each protomer, three out of five selenomethionines were found.
BpHldC shares relatively low sequence identity (30%) with its closest homologue, the lipopolysaccharide core biosynthesis protein from Thermoplasma volcanium GSS1 (PDB entry 3glv; Midwest Center for Structural Genomics, unpublished work), and the crystal structures of HldC has not yet been reported. Further studies are in progress to determine a full structure and to elucidate the structure-function relationship of the protein.
